Maze Therapeutics, Inc. (MAZE) Live Share Price, Invest From India

Maze Therapeutics, Inc. Stock Performance

as on August 20, 2026 at 6:59 am IST

Day's Low
Day's High
$29.11
Day's Price Range
$30.18
$29.77
2.22%
Downside
1.38%
Upside
52 Week's Low
52 Week's High
$12.81
52-Week Price Range
$53.65
$29.77
56.97%
Downside
80.21%
Upside

Maze Therapeutics, Inc. share price movements today

Previous Close: $29.13
Open: $29.11
Volume: 327.0K
Market Cap: $1.5B
Day's Low - High: $29.11 - $30.18
52 Week Low - High: $12.81 - $53.65

Maze Therapeutics, Inc. Historical Returns

1 Month Return: -3.34 %
3 Month Return: + 6.34 %
1 Year Return: + 101.33 %
3 Year Return: 0 %
5 Year Return: 0 %

Maze Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Maze Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-2.74

Dividend Yield

0.00%

PE Ratio (TTM)

-10.1

Industry PE ratio

-7.283372093023256

PEG Ratio

0.19232779855566887

Return On Equity TTM

-34.94%

Maze Therapeutics, Inc. Stock Valuation

Track how Maze Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Maze Therapeutics, Inc. in the last 4 years

Overview
Trends

Lowest (-13.58x)

December 31, 2025

Today (-13.58x)

December 31, 2025

Industry (-7.28x)

December 31, 2025

Highest (205.01x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -13.58x

Maze Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Maze Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Maze Therapeutics, Inc.	StrongBuy	$1.5B	NA	-10.1	95.28%	NA
Revolution Medicines	BUY	$43.7B	669.3%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$128.2B	154.86%	29.82	86.04%	NA
Regeneron	BUY	$82.7B	24.1%	19.24	84.86%	0.44999999999999996%

Stock Returns calculator for Maze Therapeutics, Inc. Stock including INR - Dollar returns

The Maze Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Maze Therapeutics, Inc. investment value today

Current value as on today

₹2,42,484

Returns

₹1,42,484

(+142.48%)

Returns from Maze Therapeutics, Inc. Stock

₹1,20,519 (+120.52%)

Dollar Impact

₹21,966 (+21.97%)

Analyst Recommendation on Maze Therapeutics, Inc. Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Maze Therapeutics, Inc.. Average target price of $66.25

Indian Investors' Interest in Maze Therapeutics, Inc. Stock

Search interest for Maze Therapeutics, Inc. Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 21, 2026 to August 20, 2026

Change:-55% versus previous 30 day period

Maze Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	165	2	-	-	-	-	20	-
Gross Profit	-	165	2	-	0	-	0	19	-
Operating Income	-23	139	-24	-35	-36	-32	-38	-26	-48
EBITDA	-25	141	-24	-32	-33	-29	-34	-22	-43
Interest Expense	-	-	-	-	-	-	-	0	0
Depreciation	0	0	0	0	0	0	0	0	-
Income Before Tax	-26	140	-25	-32	-33	-30	-34	-24	-44
Income Tax Expense	-	1	0	-	-	-	-	-	-
Net Income	-26	139	-24	-32	-33	-30	-34	-24	-44
Net Profit Margin	0.00%	100.00%	100.00%	0.00%	0.00%	0.00%	0.00%	97.78%	0.00%

Maze Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Total Revenue	-	-	167	-
Gross Profit	-	-	167	-2
Operating Income	-111	-98	57	-142
EBITDA	-111	-96	56	-128
Interest Expense	-	-	-	-
Depreciation	3	4	3	2
Income Before Tax	-114	-100	53	-131
Income Tax Expense	-	-	1	-
Net Income	-114	-100	52	-131
Net Profit Margin	0.00%	0.00%	100.00%	0.00%

Maze Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-26	139	-24	-32	-33	-30	-34	-24	-44
Operating Cash Flow	-20	145	-23	-29	-30	-24	-27	-39	-15
Investing Cash Flow	0	0	0	0	0	-66	-103	6	-128
Financing Cash Flow	16	0	-2	127	0	143	3	42	147
Change in Cash	-4	145	-25	97	-29	52	-127	9	4

Maze Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Net Income	-114	-100	52	-131
Operating Cash Flow	-99	-86	75	-111
Investing Cash Flow	-3	0	-1	-170
Financing Cash Flow	1	16	92	275
Change in Cash	-100	-70	167	-7

Mutual Funds that own Maze Therapeutics, Inc. Stock

Check out the Mutual Funds with significant holdings in Maze Therapeutics, Inc..

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.524427%	1397151
Fidelity Select Portfolios	0.563526%	311885
Fidelity Salem Street Trust	0.536067%	296688
Fidelity Concord Street Trust	0.409675%	226736
BlackRock Funds	0.333276%	184453

See all

Global Institutional Holdings in Maze Therapeutics, Inc.

Funds	Holdings
Vanguard	3.71%
iShares	3.37%
Michael Rockefeller	1.17%
Richard Driehaus	1.15%
Christopher J. Burke	0.87%

See all

Insights on Maze Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, MAZE stock has moved up by 5.8%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 374.5%

About Maze Therapeutics, Inc.

Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor that is in phase II ready clinical trial for the treatment of phenylketonuria and chronic kidney disease. The company also develops MZE001, an investigational oral small molecule inhibitor of muscle-specific glycogen synthase clinical program for the treatment of Pompe disease. It has a license agreement with Trace Neuroscience, Inc. to discovery research program targets UNC13A; the Shionogi & Co., Ltd to research, develop, manufacture, and commercialize MZE001; and Neurocrine Biosciences, Inc. to discover research program that targets ATXN2. The company was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.

Organisation	Maze Therapeutics, Inc.
Headquarters	171 Oyster Point Blvd, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
E-voting on shares	Click here to vote

Key Management of Maze Therapeutics, Inc.

Name	Title
Mr. Vipin Vijayakumar	Vice President of R&D Infrastructure and Operations
Ms. Courtney J. Phillips J.D.	General Counsel & Corporate Secretary
Ms. Nazila Habibizad	Senior Vice President of Technical Operations & Supply Chain
Mr. Maarten Hoek	Senior Vice President of Research
Mr. Misbah Tahir CPA	CFO & Principal Accounting Officer
Dr. Harold S. Bernstein M.D., Ph.D.	President of Research & Development and Chief Medical Officer
Mr. Atul Dandekar	Chief Strategy & Business Officer
Mr. Winston Tse	Senior Vice President of Drug Discovery
Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.	CEO & Director
Mr. Matt Krause	Senior Vice President of Human Resources

FAQs

What is Maze Therapeutics, Inc. share price today?

Maze Therapeutics, Inc. share price today is $29.77 as on August 20, 2026 at 1:29 am IST at the close of the market. Maze Therapeutics, Inc. share today touched a day high of $30.18 and a low of $29.11.

What is the 52 week high and 52 week low for Maze Therapeutics, Inc. share?

Maze Therapeutics, Inc. share touched a 52 week high of $53.65 on March 16, 2026 and a 52 week low of $12.81 on August 19, 2025. Maze Therapeutics, Inc. stock price today i.e. August 20, 2026 at 1:29 am IST is closed at $29.77,which is 44.51% down from its 52 week high and 132.40% up from its 52 week low.

What is Maze Therapeutics, Inc.'s market capitalisation today?

Maze Therapeutics, Inc. market capitalisation is $0.00T as on August 20, 2026 at 1:29 am IST.

How to invest in Maze Therapeutics, Inc. Stock (MAZE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Maze Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Maze Therapeutics, Inc. Shares that will get you 0.0504 shares as per Maze Therapeutics, Inc. share price of $29.77 per share as on August 20, 2026 at 1:29 am IST.

What is the minimum amount required to buy Maze Therapeutics, Inc. Stock (MAZE) from India?

Indian investors can start investing in Maze Therapeutics, Inc. (MAZE) shares with as little as ₹95.743 or $1 (as of August 20, 2026 at 4:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Maze Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on August 20, 2026 at 4:39 am IST). Based on Maze Therapeutics, Inc. share’s latest price of $29.77 as on August 20, 2026 at 1:29 am IST, you will get 0.3359 shares of Maze Therapeutics, Inc.. Learn more about fractional shares .